MedTrace Logo

Assessing Quality of Life of Patients With Stomach Cancer

NCT00020826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 267

Last updated 2012-08-27

No results posted yet for this study

Summary

RATIONALE: Assessing quality of life in patients who are undergoing cancer treatment may help determine the effect of treatment on these patients.

PURPOSE: Clinical trial to study the effectiveness of a quality of life assessment in patients who are receiving treatment for stomach cancer.

Conditions

Interventions

OTHER

quality-of-life assessment

QLQ-C30 questionnaire administered. STO22 questionnaire administered.

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Jane Blazeby, MB, CHB, FRCS, BSc, MD · University Hospitals Bristol and Weston NHS Foundation Trust

  • Thierry Conroy, MD · Centre Alexis Vautrin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2003-05-31
Completion
2004-01-31

Countries

  • France
  • Germany
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00020826 on ClinicalTrials.gov